CITI/CALL/PFIZER INC/44/0.1/19.06.25 | Market Closed - Börse Stuttgart 11:52:52 31/05/2024 BST | ||
| 0.019 EUR | +58.33% |
|
| 1 month | +171.43% | ||
| 3 months | -9.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 0.019 | +58.33% |
| 30/05/24 | 0.012 | -7.69% |
| 29/05/24 | 0.013 | -38.10% |
| 28/05/24 | 0.021 | +23.53% |
| 27/05/24 | 0.017 | +21.43% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 11:52 am
More quotesStatic data
| Product type | Warrant Plain-Vanilla |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Citi
|
| WKN | KH8MH2 |
| ISIN | DE000KH8MH24 |
| Date issued | 07/08/2023 |
| Strike | 44 $ |
| Maturity | 19/06/2025 (382 Days) |
| Parity | 10 : 1 |
| Emission price | 0.17 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.24 € |
|---|---|
| Lowest since issue | 0.006 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66
USD
Average target price
31.92
USD
Spread / Average Target
+11.36%
- Stock Market
- Warrants
- Warrant
